TOG

USPTO Trademark Record

ABANDONED

TOGETHER TARGETING OPTIMAL GOALS EARLY, IN THE HYPERTENSIVE/DYSLIPIDEMIC AT EXTRA RISK

Q: Who owns the TOGETHER TARGETING OPTIMAL GOALS EARLY, IN THE HYPERTENSIVE/DYSLIPIDEMIC AT EXTRA RISK trademark?

The TOGETHER TARGETING OPTIMAL GOALS EARLY, IN THE HYPERTENSIVE/DYSLIPIDEMIC AT EXTRA RISK trademark is owned by C.P. Pharmaceuticals International C.V..

Q: What class is the TOGETHER TARGETING OPTIMAL GOALS EARLY, IN THE HYPERTENSIVE/DYSLIPIDEMIC AT EXTRA RISK trademark registered in?

The TOGETHER TARGETING OPTIMAL GOALS EARLY, IN THE HYPERTENSIVE/DYSLIPIDEMIC AT EXTRA RISK trademark is registered in Class 042 (Scientific, technology & SaaS services).

Q: What is the serial number for TOGETHER TARGETING OPTIMAL GOALS EARLY, IN THE HYPERTENSIVE/DYSLIPIDEMIC AT EXTRA RISK?

The USPTO serial number for TOGETHER TARGETING OPTIMAL GOALS EARLY, IN THE HYPERTENSIVE/DYSLIPIDEMIC AT EXTRA RISK is 77038408.

SN 77038408·Reg 3485547·Filed Nov 07, 2006

Owner C.P. Pharmaceuticals International C.V.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

TOGETHER TARGETING OPTIMAL GOALS EARLY, IN THE HYPERTENSIVE/DYSLIPIDEMIC AT EXTRA RISK (Serial No. 77038408), Registration No. 3485547, is a abandoned US trademark filed on Nov 07, 2006 by C.P. Pharmaceuticals International C.V.. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

TOGETHER TARGETING OPTIMAL GOALS EARLY, IN THE HYPERTENSIVE/DYSLIPIDEMIC AT EXTRA RISK (Reg. #3485547) is an abandoned US trademark that was filed in 2006 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Nov 07, 2006

SERIAL

77038408

REG#

3485547

REGISTERED

Aug 12, 2008

Owner

Applicant

C.P. Pharmaceuticals International C.V.

Entity

Limited Partnership

Address

235 East 42nd Street, New York, NY, 10017

Country

Attorney

NameRichard Friedman

Law firm

Richard Friedman PFIZER INC.

Docket

TMID 223859

Address

150 E 42ND ST FL 5, Legal Division - Trademark Dept., NEW YORK, NY 10017-5612, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateNov 07, 2006

Serial Number77038408

Registration No.3485547

Registration DateAug 12, 2008

Status DateMar 13, 2015

Published for OppositionAug 21, 2007

Mark TypeDesign with words

Attorney DocketTMID 223859

Status DescriptionDead and cancelled, Section 8

Filing Signals

FILED

2006

YEARS AGO

20y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Feb 28, 2007

First use in commerce: Feb 28, 2007

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

25 events

CANCELLED SEC. 8 (6-YR)

Mar 13, 2015

CANCELLED SEC. 8 (6-YR)

REGISTERED-PRINCIPAL REGISTER

Aug 12, 2008

REGISTERED-PRINCIPAL REGISTER

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jul 07, 2008

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

ASSIGNED TO LIE

Jul 07, 2008

ASSIGNED TO LIE

LAW OFFICE REGISTRATION REVIEW COMPLETED

Jul 07, 2008

LAW OFFICE REGISTRATION REVIEW COMPLETED

STATEMENT OF USE PROCESSING COMPLETE

Jun 05, 2008

STATEMENT OF USE PROCESSING COMPLETE

TEAS STATEMENT OF USE RECEIVED

May 30, 2008

TEAS STATEMENT OF USE RECEIVED

USE AMENDMENT FILED

May 30, 2008

USE AMENDMENT FILED

SOU EXTENSION 1 GRANTED

May 08, 2008

SOU EXTENSION 1 GRANTED

SOU TEAS EXTENSION RECEIVED

Apr 29, 2008

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Apr 29, 2008

SOU EXTENSION 1 FILED

NOA MAILED - SOU REQUIRED FROM APPLICANT

Nov 13, 2007

NOA MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Aug 21, 2007

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Aug 01, 2007

NOTICE OF PUBLICATION

LAW OFFICE PUBLICATION REVIEW COMPLETED

May 16, 2007

LAW OFFICE PUBLICATION REVIEW COMPLETED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 14, 2007

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

Apr 26, 2007

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 26, 2007

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 26, 2007

TEAS/EMAIL CORRESPONDENCE ENTERED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 26, 2007

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION MAILED

Mar 16, 2007

NON-FINAL ACTION MAILED

ASSIGNED TO EXAMINER

Mar 15, 2007

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Mar 15, 2007

NON-FINAL ACTION WRITTEN

NOTICE OF DESIGN SEARCH CODE MAILED

Nov 14, 2006

NOTICE OF DESIGN SEARCH CODE MAILED

NEW APPLICATION ENTERED

Nov 13, 2006

NEW APPLICATION ENTERED

TOGETHER TARGETING OPTIMAL GOALS EARLY, IN THE HYPERTENSIVE/DYSLIPIDEMIC AT EXTRA RISK

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by C.P. Pharmaceuticals International C.V.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by Richard Friedman

Resources

Company